Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D L Sigalet

Showing results (1-10 of 40) with videos related to

Pageof 4
Sort By:
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
ALX-0600 (NPS Allelix Corp)D L Sigalet
Seminars in Pediatric Surgery|May 1, 2001
Short bowel syndrome in infants and children: an overviewD L Sigalet
Journal of Animal Science|November 22, 2011
Nonruminant Nutrition Symposium: The role of glucagon-like peptide-2 in controlling intestinal function in human infants: regulator or bystander?D L Sigalet
Seminars in Pediatric Surgery|October 22, 2018
Advances in glucagon like peptide-2 therapy. physiology, current indications and future directionsD L Sigalet
Journal of Pediatric Surgery|February 18, 1999
Lymphatic absorption of glucose and fatty acids as determined by direct measurementD L Sigalet, G Martin
Journal of Pediatric Surgery|July 11, 1998
Mechanisms underlying intestinal adaptation after massive intestinal resection in the ratD L Sigalet, G R Martin
Journal of Pediatric Surgery|February 29, 2000
Hormonal therapy for short bowel syndromeD L Sigalet, G R Martin
Journal of Pediatric Surgery|January 11, 2001
Portal venous decompression with H-type mesocaval shunt using autologous vein graft: a North American experienceD L Sigalet, S Mayer, H Blanchard
Journal of Pediatric Surgery|May 17, 2000
Differential sugar absorption as a marker for adaptation in short bowel syndromeD L Sigalet, G R Martin, A Poole
Journal of Pediatric Surgery|May 1, 2001
In vivo measurement of intestinal absorption using 3-0 methylglucose in short bowel syndromeE Debru, G R Martin, D L Sigalet
Pageof 4

Showing results (1-10 of 40) with videos related to

Sort By:
Pageof 4
Current Opinion in Investigational Drugs (London, England : 2000)|September 22, 2001
ALX-0600 (NPS Allelix Corp)D L Sigalet
Seminars in Pediatric Surgery|May 1, 2001
Short bowel syndrome in infants and children: an overviewD L Sigalet
Journal of Animal Science|November 22, 2011
Nonruminant Nutrition Symposium: The role of glucagon-like peptide-2 in controlling intestinal function in human infants: regulator or bystander?D L Sigalet
Seminars in Pediatric Surgery|October 22, 2018
Advances in glucagon like peptide-2 therapy. physiology, current indications and future directionsD L Sigalet
Journal of Pediatric Surgery|February 18, 1999
Lymphatic absorption of glucose and fatty acids as determined by direct measurementD L Sigalet, G Martin
Journal of Pediatric Surgery|July 11, 1998
Mechanisms underlying intestinal adaptation after massive intestinal resection in the ratD L Sigalet, G R Martin
Journal of Pediatric Surgery|February 29, 2000
Hormonal therapy for short bowel syndromeD L Sigalet, G R Martin
Journal of Pediatric Surgery|January 11, 2001
Portal venous decompression with H-type mesocaval shunt using autologous vein graft: a North American experienceD L Sigalet, S Mayer, H Blanchard
Journal of Pediatric Surgery|May 17, 2000
Differential sugar absorption as a marker for adaptation in short bowel syndromeD L Sigalet, G R Martin, A Poole
Journal of Pediatric Surgery|May 1, 2001
In vivo measurement of intestinal absorption using 3-0 methylglucose in short bowel syndromeE Debru, G R Martin, D L Sigalet
Pageof 4